| Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | b-lacam/b-lactamase inhibitor, semisynthetic (amino-penicilling with enhanced uptake through porin channels due to pos charge) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | IV 3rd/4th gen, pseudomonas aeruginosa coverage |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | B-Lactam antibiotic from thienamycin Cilastatin inhibits dehydropeptidase-1, an enzyme that metabolizes imipenem. Without it, imipenem would cause toxicity to the proximal tubule.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | IV 3rd gen ceph, serious gram neg organisms, penetrates CSF |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | IV B-lactamase inhibitor (tazo), Semisynthetic 4th generation, Systemic pseudomonas infections |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | synthetic oxazolidinone, PO/IV, gram Pos activity used in VRE cases |  | 
        |  | 
        
        | Term 
 
        | broad spectrum penicillin |  | Definition 
 
        | 2nd gen: ampicillin, amoxicillin, 3rd gen: carbenicillin, ticarcillin, 4th gen: piperacillin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | clavulanate, sulbactam, tazobactam and avilbactam |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ampicillin, amoxicillin, bacampicillin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nafcillin, oxacillin, cloxacillin, and dicloxacillin |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | ureidopenicillins (azlocillin, mezlocillin, piperacillin), carboxypenicillins (ticarcillin, carbenicillin) and mecilinam |  | 
        |  |